Study results show the candidate has demonstrated significantly higher antibodies against Omicron
News
NICE recommendation expands patient eligibility for AbbVie’s Ozurdex
Treatment becomes an option for treating visual impairment caused by diabetic macular oedema, regardless of lens status
MHRA grants marketing authorisation for Novartis’ Pluvicto
Radioligand therapy involves patients with advanced prostate cancer in Great Britain
Medicines Discovery Catapult and Zeiss join forces
Partnership will focus on driving the application of microscopy in drug discovery
Key blood clotting protein could be ‘warning light’ for COVID-19 cases
University of Aberdeen team suggest results indicate that protein PAI-1 could be an early indicator of severe COVID-19
SMC approve Johnson & Johnson’s systemic light chain amyloidosis therapy
Newly diagnosed patients will become the first to access systemic light chain amyloidosis treatment in the UK
Cerevance establishes strategic research collaboration with Merck
Partnership will focus on the discovery of novel targets in Alzheimer’s disease
Verona’s ensifentrine meets primary endpoint
Chronic obstructive pulmonary disease phase 3 study shows statistically significant improvements in lung function
Arecor granted European patents to protect Humira formulations
Patents show potential of innovative Arestat technology and the development of enhanced formulations
SyneuRx reveals results of COVID-19 candidate trial
Positive data show Pentarlandir is safe and effective in patients with mild-to-moderate COVID-19
EQRx announces further results from phase 3 trial of sugemalimab
Study involved patients with locally advanced, unresectable stage 3 non-small cell lung cancer
South Tees NHS Trust reaches e-prescribing milestone by implementing Alcidion
Better Meds is already removing paper forms and manual processes from NHS Trust’s system
Sanofi and Innovent Biologics enter strategic collaboration
Partnership will accelerate development of oncology medicines and expand presence in China
NHS leaders call for concrete proposals
Senior NHS figures fear that the leadership contest is not addressing wider health service needs
Open Orphan to commence influenza human challenge study
Candidate exhibits a novel mechanism of action and differs considerably from previously approved drugs
